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There is a growing interest in understanding the mechanisms that drive the developmental origins
of health and disease, and the role of epigenetic regulation has risen to the forefront of these
studies. In particular, the placenta may be a model organ to consider as a mediator of the impact of
the environment on developmental programming of children’s health, as this organ plays a critical
role in directing development and regulating the fetal environment. Several recent studies have
begun to examine how environmental toxicant exposures can impact the placental epigenome,
focusing on studies of DNA methylation and microRNA expression. This review highlights
several of these studies and emphasizes the potential the placenta may hold on the broader
understanding of the impact of the intrauterine environment on long-term health.

placenta; DNA methylation; fetal programming; biomarker; developmental origins; microRNA
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The theory of developmental origins of health and disease (DOHaD) posits that the
environment encountered during gestation impacts fetal development to allow elaboration of
the single fetal genome to accommodate variation in phenotypes which are responsive or
adaptive to the predicted external environment. Elegant epidemiologic studies have taken
advantage of natural experiments, including the Dutch Famine of World War II and the
Quebec ice storm of 1998 to demonstrate the impact of extreme environmental conditions on
infant, childhood, and long-term health outcomes.1–8 Birth weight, as a marker of the quality
of the intrauterine environment, has also been linked to adult diseases and disorders
including metabolic syndrome, cardiovascular disease, obesity, diabetes, and mental health
conditions.9–13
Building on this research, contemporary studies are aiming to elucidate how specific
environmental factors, including maternal nutrition, psychosocial profile, drugs, xenobiotics
and environmental contaminants, maternal metabolic status, and infection, can impact early
childhood and long-term health. Importantly, these studies are also beginning to enumerate
mechanisms underlying these effects in the hopes that interventional efforts may become
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apparent. This review will focus on such studies, specifically those focusing on
environmental contaminants and the utility of the placenta and epigenetic biomarkers in the
placenta to contribute to the understanding of the mechanisms underlying gestational
environmental contribution to long-term health.

The Placenta’s Role in DOHaD

Author Manuscript

Central to understanding the mechanisms underlying DOHaD is the placenta. David Barker,
who delineated the “Thrifty Phenotype” giving rise to the current concept of DOHaD,
devoted much of his work to linking gross placental characteristics such as placental size to
adult metabolic outcomes as well as understanding the predictors of those placental
measures.14–18 Such work continues, and new visual morphometric tools are being used to
demonstrate how morphologic and pathologic variation of the placenta can influence
childhood growth and potentially other outcomes.19–21 Understanding molecular features of
cells responsible for placental function, though, holds additional promise in providing
fundamental insights into the effects of environmental contaminants and their effects.
The critical roles of the placenta in fetal development make it an excellent organ of focus to
consider as a mediator of the environment on fetal, infant, and potentially lifelong health.
The placenta sits at the interface of the maternal and fetal environment, controlling fetal
development and environment through a variety of critical functions (Table 1). It is the first
complex organ to form during development, and can be impacted at the earliest stages by
maternal environmental factors leading to adaptations which can both positively and
negatively impact the course of gestation. Environmental toxicants can significantly impact
fetal development by impairing or altering the placenta’s ability to perform these
functions.22,23

Author Manuscript

Appropriate placental gene expression is paramount to fetal regulation during pregnancy,
and alterations from this have been linked to preeclampsia, intrauterine growth restriction,
gestational diabetes mellitus, and trophoblastic disease.25–29 While characterizing gene
expression patterns can aid in pinpointing critical pathways involved in disease
pathogenesis, an additional layer of examination, considering how these expression patters
become impacted is necessary to fully describe toxicant effects on the placenta and thus
impacting health.

Epigenetic Mechanisms and the Placenta

Author Manuscript

Epigenetic mechanisms are those which control gene expression or gene expression
potential in a mitotically stable fashion without altering the underlying sequence of the
DNA. Fundamentally, epigenetic mechanisms regulate the conformation and accessibility of
chromatin to transcription factors and the transcriptional machinery’s ability to generate
RNA from the DNA sequence.
Histones, the proteins which constitute the nucleosome core, represent the most active sites
of epigenetic regulation, as tails of these proteins which are accessible from the nucleosome
core can be posttranslationally modified with a variety of moieties leading both to changes
in the physical accessibility of the DNA they encase, and also to signaling to transcriptional
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activators and repressors to control transcription. The histone modification landscape,
although highly relevant in controlling gene expression patterns in the placenta and all other
tissues, has been less well characterized, particularly in human studies, as the methodologies
required for its characterization are thus far not amenable to large-scale population studies.
Chromatin immunoprecipitation techniques required for colocalizing modified histones with
their coincident DNA rely on antibodies which can have challenges in their reproducibility,
as well as access to pristine, freshly collected, and fairly large quantities of samples, which
may not be feasible in epidemiologic contexts.

Author Manuscript

On the other hand, modification of the DNA itself, in the form of cytosine methylation, has
been well characterized in human studies. DNA methylation often occurs coincidentally
with repressive histone modifications, and in the context of CpG methylation within
promoter or proximal promoter region, CpG-rich (CpG island) areas can signal gene
silencing. DNA methylation can be interrogated using sodium bisulfite modification of
genomic DNA.30 This technique leads to the deamination of all unmethylated cytosines in
the genome to uracil, while methylated cytosines are retained. Following amplification, the
methylation status can be determined by methylation-specific PCR or sequencing strategies,
including short-read quantitative pyrosequencing or mass spectrometry–based techniques as
well as next-generation sequencing technologies, simply by denoting the presence or
absence of cytosine in the sequence. It is worthy to note that when performed quantitatively,
the percent methylation being reported at any site is really a reflection of the number of
methylated alleles within a given sample, and is more reflective of the number of cells
demonstrating a methylated state, as any one allele can be only methylated or not.
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There is a growing literature of studies examining the DNA methylation status of specific
candidate genes, as well as markers of global DNA methylation, and variation in genomewide DNA methylation in the placenta.31 Owing to the importance of the placenta in
development, links have been made between variation in placental DNA methylation and
newborn outcomes including growth and birth weight, gestational age, and behavior.32–36 In
addition, various pregnancy conditions and complications, including preeclampsia,
gestational diabetes, and maternal obesity, have been linked to placental DNA methylation
profiles.37–44
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An additional level of epigenetic control, at the posttranscriptional level, is directed by
noncoding RNA, and specifically microRNA (miRNA). MiRNAs are small, approximately
22 nucleotides, noncoding RNA molecules, which are highly ubiquitous and possess
conservation across many species.45 MiRNAs posttranscriptionally regulate gene expression
by base-pairing to the 3′-untranslated region of a target mRNA resulting in either
translational repression or direct degradation of the mRNA, the exact mechanism of which
depends largely on the degree of complementarity of the miRNA to its mRNA target.
Because partial complementarity of a miRNA to an mRNA target can still lead to
translational repression, a single miRNA has the capability of regulating a large number of
genes.46 MiRNAs have been implicated in regulating numerous cellular processes and play
a critical role in mammalian development.47,48 Highly conserved clusters of primatespecific miRNA are expressed in the placenta and other tissues49,50 and interestingly,
similar patterns of regulation of these conserved miRNA have been described in placenta
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and brain.50 Altered miRNA expression has been linked to several maternal–placental
conditions such as preeclampsia51– 55 and growth restriction,56 reinforcing the role for
placental miRNA as clinical biomarkers of exposure or disease.57 In fact, the C19MC
miRNA cluster plays critical role in placental trophoblast migration, maternal immune
system regulation, possibly through their secretion as exosomes acting as intercellular
signals.49,58–61

Author Manuscript

As it is clear that maternal factors can contribute to the epigenomic landscape of the
placenta, and that this level of epigenetic regulation can impact placental function and
children’s health, there is a growing interest from the environmental epidemiology
community to consider placental epigenetics as a mediator of the maternal toxicant
environment on children’s health outcomes. This more complete understanding of the
central role of the placenta and its molecular landscape holds the hope of providing risk
predictors and biomarkers to help clinicians better diagnose and treat complex disease and to
provide insights to the pathologic process. In the following sections, we highlight recent
work considering the impacts of selected environmental toxicants on placental epigenetic
profiles and how these link to important newborn and early life outcomes.

Environmental Exposures and DNA Methylation

Author Manuscript

Endocrine disrupting chemicals (EDCs) are generally considered to be a wide-ranging group
of compounds that, at certain doses, act to alter the function of hormones within mammals.62
Common chemicals with broad use and so nearly universal exposure that fall within this
category include phenols such as bisphenol A (BPA), or phthalates, which are important
plasticizers used often in food packaging. In most cases, the toxic activity of EDCs is not
entirely through their hormonal effects, and there remain significant questions regarding
how they impact wide-raging human health conditions particularly during the prenatal
period.63 Experimentally in a murine model, BPA has been shown to affect the epigenome
through alteration of the DNA methylation status of the metastable Agouti allele in mice, a
phenomenon which can be reversed by nutritional supplementation with methyl donors
(folic acid).64 Importantly, animal models have demonstrated that the liver’s ability to
metabolize BPA into its inactivated state is reduced by 40% during pregnancy,65 suggesting
an acute susceptibility to endocrine disruptors during this period for both the mother and
fetus. Human studies mimic these findings, demonstrating that pregnant women excreted
26% greater levels of BPA in their urine as compared with pre-pregnancy.66

Author Manuscript

Recent work has begun to examine the potential epigenetic effects of EDCs in human
populations. Nahar et al demonstrated that in utero exposure to BPA altered expression of
xenobiotic metabolizing enzymes (XMEs) in human fetal liver tissue through site-specific
methylation of the Catechol-O-methyltransferase (COMT) genes and average methylation
differences of the sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)preferring, member 1 (SULT2A1) gene by BPA exposure level.67 Increasing maternal levels
of the sum of phthalate metabolites assessed in maternal urine were negatively correlated
with placental methylation of the imprinted genes H19 and insulin-like growth factor 2
(IGF2).68 H19 and IGF2 form a gene cluster on human chromosome 11, and have been
shown to be heavily regulated by epigenetic mechanisms (common among imprinted genes)
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with IGF2 acting as an important fetal growth factor.69 Together, these preliminary findings
suggest that EDC exposure has the potential to impact fetal and child health through
variation in placental methylation, though a more thorough investigation is required.
Many metals and metalloids found in the environment, including cadmium, and mercury
pose potential health hazards, and are becoming increasingly studied for their effects during
gestation. In many cases, the toxic mechanisms of these exposures are unclear and
epigenetic effects have become increasingly investigated as the potential pathways through
which these exposures impact human health.

Author Manuscript

Cadmium exposure primarily occurs through cigarette smoke and dietary intake, with high
levels found in offal meats, crustaceans, mollusks, and some leafy greens.70,71 Cadmium is a
transplacental toxic metal, accumulating in and passing through the placenta to the fetal
circulation, and has been implicated as a potential cause of adverse birth outcomes,
including birth weight and head circumference, although this effect may be sex specific.72

Author Manuscript

The epigenetic influence of this metal is now a topic of study, including work in a rat model,
where prenatal exposure to cadmium altered methylation of the hepatic glucocorticoid
receptor.73 This parallels human in vitro data demonstrating an altered glucocorticoid
response in human placental trophoblasts following cadmium exposure.74 In cord blood
DNA, cadmium exposure could be associated with variable DNA methylation which also
demonstrated sex specificity. Correlations between exposure levels and methylation in boys
were predominantly positive (96% of the top 500 CpG sites), while in girls only 29% of the
top 500 correlated CpG sites showed a positive relationship. In addition, the genes showing
strong correlations to cadmium levels differed between the sexes, as girls were
predominantly affected in genes related to organ development, while changes in boys were
in cell-death–related genes. Though the authors had previously described an inverse
relationship between cadmium and birth weight in girls, this study was unable to identify
specific CpG sites affecting birth weight.75
Mechanisms of mercury toxicity also remain enigmatic, although mercury exposure in early
life is associated with adverse neurodevelopmental outcomes,76,77 including reduced
newborn cerebellum size,78 adverse behavioral outcomes,79 central nervous system
damage,80 poor psychomotor development,81 and cognitive developmental delays.82 Other
effects which may not appear until later life, such as increased type II diabetes susceptibility,
have also been reported.83,84

Author Manuscript

Mercury crosses the placenta85,86 and interferes with placental functioning.87 Twice the
concentration of methylmercury, the predominant form of mercury exposure, has been found
in placenta compared with maternal blood.88 A common source of mercury exposure is
maternal fish consumption,89 although maternal dental amalgams with inorganic
mercury89,90 can also increase placental mercury. A single maternal amalgam restoration
has been associated with a three- to sixfold increase in placental mercury.90 There has been
limited examination of mercury exposure associated with molecular features of the
developing placenta, although a recent epigenome-wide study identified hypomethylation of
the EMID2 gene associated with infant mercury exposure in utero and linked the altered
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methylation status of this gene to an adverse neurobehavioral profile characterized by
significantly higher arousal, excitability, signs of stress or abstinence, and hypertonic motor
tone, with poorer self-regulation and quality of movement compared with non–high-risk
infants.91 Although requiring replication and expansion, these preliminary studies suggest a
potential epigenetic mode of mercury’s toxic activity which can be considered.

Placental miRNA Expression and Environmental Exposures

Author Manuscript

Initial studies in lymphoblastoid cell lines demonstrated the potential responsiveness of
miRNA expression to cellular stressors, including folate deficiency and arsenic exposure.92
In vitro studies using placental trophoblast models identified miR-146a to be induced with
exposure to BPA, and that the overexpression of this miRNA in trophoblasts led to
decreases in cellular proliferation and increased sensitivity to DNA damaging agents,
denoting an important potential mechanism for coexposure synergism.93 Other studies have
also demonstrated associations between miRNA expression in human cells and exposure to
trace metals (reviewed in Baccarelli and Bollati94), including Cd,95 As, and Pb,96 and metalrich particulates.97 Although a relatively new area in environmental health research, studies
focusing on miRNA hold significant potential to improve our understanding of the health
effects of various environmental contaminants including the wide-ranging and long-term
effects of these exposures.

Conclusion and Future Directions

Author Manuscript
Author Manuscript

There is growing interest in studies of the placenta as a mediator of the intrauterine
environment, and highlighted here was only a sampling of the work considering the effects
of environmental toxicants on the placental epigenome. This complements the work
considering the impact of maternal nutrition and health, psychosocial factors, genetics, and
drugs including pharmaceuticals, as well as the burgeoning work considering the paternal
contribution to children’s long-term health. Yet, it highlights the urgent need for crossdisciplinary studies that can more appropriately integrate all of these environmental factors,
as none occur in a vacuum, and all, likely, in some way contribute to long-term
developmental programming. The placenta and its molecular characteristics can thus
potentially serve as an integrated assessment of the complicated interplay of all of these
factors, and in so doing not only provided a biomarker of exposure but one of effect to better
characterize the mechanisms driving DOHaD. For the long-term implications of the
placental epigenome to be fully realized, long-term longitudinal studies linking the placental
epigenetic landscape to children’s outcomes will be needed. As more studies begin to
incorporate placental collections and assessments, there will be growing opportunities to
combine resources and develop highly integrated studies to tackle some of the most
complicated effects of the intrauterine environment, as well as to inform potential avenues
of intervention and prevention.
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Key functions of the placenta24
Transport
  • Nutrients, water, waste, gases
Metabolism
  • Glucose, amino acids, lipids
Protection
  •Export pumps, xenobiotic metabolism, glucocorticoid regulation, physical barrier, immune regulation
Endocrine
  • Estrogens, growth factors, cytokines, chemokines, angiogenic factors, pregnancy hormones, neuropeptides
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